Selegiline and Parkinson's disease. Protective and symptomatic considerations.
Golbe
L I
LI
University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick.
Langston
J W
JW
Shoulson
I
I
D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D010627:Phenethylamines / Q000627:therapeutic use*; D012642:Selegiline / Q000627:therapeutic use*
D010627:Phenethylamines; D012642:Selegiline